$AHRO
Authentic Holdings, Inc. Stock $ahro

$ahro Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000147793224007452 Filed on November 19, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2023 Q4
Revenue		$97.10K	$0.00
YoY Change
Cost Of Revenue		$42.68K	$0.00
YoY Change
Gross Profit		$54.42K	$0.00
YoY Change
Gross Profit Margin		56.05%
Selling, General & Admin			$45.70K
YoY Change
% of Gross Profit
Research & Development		$0.00	$2.000K
YoY Change		-100.0%	-97.14%
% of Gross Profit		0.0%
Depreciation & Amortization			$270.6K
YoY Change			2606.4%
% of Gross Profit
Operating Expenses		$222.4K	$312.1K
YoY Change		162.68%	290.11%
Operating Profit		-$167.9K	-$312.1K
YoY Change		98.39%	290.11%
Interest Expense			-$55.64K
YoY Change			-94.55%
% of Operating Profit
Other Income/Expense, Net		$0.00	-$62.04K
YoY Change		-100.0%
Pretax Income			-$711.1K
YoY Change			-35.36%
Income Tax
% Of Pretax Income
Net Earnings		-$361.0K	-$711.1K
YoY Change		-49.86%	-35.36%
Net Earnings / Revenue		-371.79%
Basic Earnings Per Share
Diluted Earnings Per Share			$0.00
COMMON SHARES
Basic Shares Outstanding	2.253B shares	2.240B shares	1.978B shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q3	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments		$0.00
YoY Change
Cash & Equivalents	$125.00	$0.00
Short-Term Investments
Other Short-Term Assets		$625.0K
YoY Change		-0.79%
Inventory
Prepaid Expenses
Receivables	$33.53K	$0.00
Other Receivables
Total Short-Term Assets	$658.7K	$625.0K
YoY Change	46.18%	0.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$0.00	$21.72K
YoY Change	-100.0%	-68.15%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$4.394M	$4.793M
YoY Change	8611.63%	5429.65%
TOTAL ASSETS
Total Short-Term Assets	$658.7K	$625.0K
Total Long-Term Assets	$4.394M	$4.793M
Total Assets	$5.053M	$5.418M
YoY Change	908.55%	661.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$316.9K
YoY Change		37.77%
Accrued Expenses		$501.3K
YoY Change		0.25%
Deferred Revenue
YoY Change
Short-Term Debt		$2.612M
YoY Change		4.47%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.387M	$5.624M
YoY Change	-3.65%	7.56%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities		$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.387M	$5.624M
Total Long-Term Liabilities		$0.00
Total Liabilities		$5.624M
YoY Change		7.53%
SHAREHOLDERS EQUITY
Retained Earnings	-$38.55M	-$38.04M
YoY Change	3.28%	4.56%
Common Stock	$2.253M	$2.024M
YoY Change	20.09%	29.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$333.9K	-$205.5K
YoY Change
Total Liabilities & Shareholders Equity	$5.053M	$5.418M
YoY Change	908.55%	661.3%

Cashflow Statement

Concept	2024 Q3	2023 Q4
OPERATING ACTIVITIES
Net Income	-$361.0K	-$711.1K
YoY Change	-49.86%	-35.36%
Depreciation, Depletion And Amortization		$270.6K
YoY Change		2606.4%
Cash From Operating Activities		$42.77K
YoY Change		-161.1%
INVESTING ACTIVITIES
Capital Expenditures		$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-42.77K
YoY Change		-171.28%
NET CHANGE
Cash From Operating Activities		42.77K
Cash From Investing Activities		0.000
Cash From Financing Activities		-42.77K
Net Change In Cash		0.000
YoY Change		-100.0%
FREE CASH FLOW
Cash From Operating Activities		$42.77K
Capital Expenditures		$0.00
Free Cash Flow		$42.77K
YoY Change		-161.1%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q3	us-gaap	Bank Overdrafts BankOverdrafts	313	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	416466	usd
CY2024Q3	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	501250	usd
CY2024Q3	us-gaap	Unsecured Debt UnsecuredDebt	163689	usd
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2252573721	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2024420237	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	2252573	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	2024420	usd
CY2024Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1248041	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5623581	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1633052	usd
CY2023Q4	ahro	Advances From Related Parties Current AdvancesFromRelatedPartiesCurrent	560779	usd
CY2024Q3	ahro	Advances Current AdvancesCurrent	625000	usd
CY2023Q4	ahro	Advances Current AdvancesCurrent	625000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	658652	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	625000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	0	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21721	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4394233	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4771322	usd
CY2024Q3	us-gaap	Assets Assets	5052885	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	316873	usd
CY2023Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	501250	usd
CY2023Q4	us-gaap	Unsecured Debt UnsecuredDebt	159950	usd
CY2024Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1450522	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1320858	usd
CY2024Q3	ahro	Convertible Notes And Accrued Interest Related Party ConvertibleNotesAndAccruedInterestRelatedParty	88943	usd
CY2023Q4	ahro	Convertible Notes And Accrued Interest Related Party ConvertibleNotesAndAccruedInterestRelatedParty	87068	usd
CY2024Q3	us-gaap	Notes Payable Current NotesPayableCurrent	101550	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	41022	usd
CY2024Q3	ahro	Promissory Notes And Accrued Interest Current PromissoryNotesAndAccruedInterestCurrent	0	usd
CY2023Q4	ahro	Promissory Notes And Accrued Interest Current PromissoryNotesAndAccruedInterestCurrent	25000	usd
CY2024Q3	ahro	Promissory Note And Accrued Interest Related Party Current PromissoryNoteAndAccruedInterestRelatedPartyCurrent	519020	usd
CY2023Q4	ahro	Promissory Note And Accrued Interest Related Party Current PromissoryNoteAndAccruedInterestRelatedPartyCurrent	508959	usd
CY2024Q3	ahro	Advances From Related Parties Current AdvancesFromRelatedPartiesCurrent	484974	usd
CY2024Q3	ahro	Related Party Debt And Interest Payable Current RelatedPartyDebtAndInterestPayableCurrent	279983	usd
CY2023Q4	ahro	Related Party Debt And Interest Payable Current RelatedPartyDebtAndInterestPayableCurrent	274456	usd
CY2024Q3	ahro	Self Liquidating Promissory Notes SelfLiquidatingPromissoryNotes	132083	usd
CY2023Q4	ahro	Self Liquidating Promissory Notes SelfLiquidatingPromissoryNotes	192500	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5386834	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3500000000	shares
CY2024Q3	ahro	Common Stock Issuable CommonStockIssuable	52200	usd
CY2023Q4	ahro	Common Stock Issuable CommonStockIssuable	16500	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	35912295	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	35791910	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-38551622	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-38038768	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-333949	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-205538	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5052885	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5418043	usd
	ahro	Advances Policy Textblock AdvancesPolicyTextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Advances are amounts provided to Inventel Products LLC for the production of vinyl records, to be sold through the Company’s joint venture.</p>
	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant items subject to such estimates and assumptions include the valuation of stock-based awards issued and derivatives embedded in financial instruments. Assessments are used to determine depreciation, the valuation of non- cash issuances of common stock, stock options, and warrants, and valuing convertible notes for beneficial conversion features, among others.</p>
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	125	usd
CY2023Q4	us-gaap	Assets Assets	5418043	usd
CY2024Q3	ahro	Related Party Transaction Amounts Of Convertible Notes And Accrued Interest RelatedPartyTransactionAmountsOfConvertibleNotesAndAccruedInterest	88943	usd
CY2024Q3	ahro	Related Party Transaction Amounts Of Related Party Loans RelatedPartyTransactionAmountsOfRelatedPartyLoans	283120	usd
CY2024Q3	ahro	Related Party Transaction Amounts Of Total Related Parties Loans RelatedPartyTransactionAmountsOfTotalRelatedPartiesLoans	891083	usd
CY2024Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	501250	usd
CY2024Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	38406181	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	38038768	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.21	pure
CY2024Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	8065298	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	7988141	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001338929
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2024420237	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2252573721	shares
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	600000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	604762	shares
CY2024Q3	ahro	Related Party Transaction Amounts Of Promissory Note And Accrued Interest05 RelatedPartyTransactionAmountsOfPromissoryNoteAndAccruedInterest05	519020	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-52047
	dei	Entity Registrant Name EntityRegistrantName	AUTHENTIC HOLDINGS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	11-3746201
	dei	Entity Address Address Line1 EntityAddressAddressLine1	50 Division Street
	dei	Entity Address City Or Town EntityAddressCityOrTown	Somerset
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	08873
	dei	City Area Code CityAreaCode	732
	dei	Local Phone Number LocalPhoneNumber	695-4389
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2252573721	shares
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	33527	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0	usd
CY2023Q4	us-gaap	Bank Overdrafts BankOverdrafts	1814	usd
CY2024Q3	us-gaap	Revenues Revenues	97096	usd
CY2023Q3	us-gaap	Revenues Revenues	0	usd
	us-gaap	Revenues Revenues	164668	usd
	us-gaap	Revenues Revenues	0	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	42675	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	0	usd
	us-gaap	Cost Of Revenue CostOfRevenue	85094	usd
	us-gaap	Cost Of Revenue CostOfRevenue	0	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	54421	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	0	usd
	us-gaap	Gross Profit GrossProfit	79574	usd
	us-gaap	Gross Profit GrossProfit	0	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	70136	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	51708	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	194260	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	160423	usd
CY2024Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	126019	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	13283	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	398810	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	36237	usd
CY2024Q3	us-gaap	Professional Fees ProfessionalFees	26211	usd
CY2023Q3	us-gaap	Professional Fees ProfessionalFees	14200	usd
	us-gaap	Professional Fees ProfessionalFees	80005	usd
	us-gaap	Professional Fees ProfessionalFees	97298	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5463	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1017	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	54858	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	222366	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	84654	usd
	us-gaap	Operating Expenses OperatingExpenses	674092	usd
	us-gaap	Operating Expenses OperatingExpenses	348816	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-167945	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-84654	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-594518	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-348816	usd
CY2024Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-54504	usd
CY2023Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-563106	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	385011	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-348623	usd
CY2024Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-84938	usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-97125	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-46153	usd
CY2024Q3	us-gaap	Financing Interest Expense FinancingInterestExpense	47786	usd
CY2023Q3	us-gaap	Financing Interest Expense FinancingInterestExpense	65324	usd
	us-gaap	Financing Interest Expense FinancingInterestExpense	189385	usd
	us-gaap	Financing Interest Expense FinancingInterestExpense	141087	usd
CY2024Q3	ahro	Interest Expense Related Parties InterestExpenseRelatedParties	5820	usd
CY2023Q3	ahro	Interest Expense Related Parties InterestExpenseRelatedParties	6817	usd
	ahro	Interest Expense Related Parties InterestExpenseRelatedParties	16837	usd
	ahro	Interest Expense Related Parties InterestExpenseRelatedParties	12690	usd
CY2024Q3	ahro	Income Loss On Joint Venture IncomeLossOnJointVenture	0	usd
CY2023Q3	ahro	Income Loss On Joint Venture IncomeLossOnJointVenture	0	usd
	ahro	Income Loss On Joint Venture IncomeLossOnJointVenture	0	usd
	ahro	Income Loss On Joint Venture IncomeLossOnJointVenture	-50000	usd
CY2024Q3	us-gaap	Other Expenses OtherExpenses	0	usd
CY2023Q3	us-gaap	Other Expenses OtherExpenses	0	usd
	us-gaap	Other Expenses OtherExpenses	0	usd
	us-gaap	Other Expenses OtherExpenses	0	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-193048	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-635247	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	81664	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-598553	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-360993	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-719901	usd
	us-gaap	Profit Loss ProfitLoss	-512854	usd
	us-gaap	Profit Loss ProfitLoss	-947369	usd
CY2024Q3	ahro	Weighted Average Common Shares Outstanding Basic And Diluted WeightedAverageCommonSharesOutstandingBasicAndDiluted	2247546547	shares
CY2023Q3	ahro	Weighted Average Common Shares Outstanding Basic And Diluted WeightedAverageCommonSharesOutstandingBasicAndDiluted	1970198093	shares
	ahro	Weighted Average Common Shares Outstanding Basic And Diluted WeightedAverageCommonSharesOutstandingBasicAndDiluted	2172891210	shares
	ahro	Weighted Average Common Shares Outstanding Basic And Diluted WeightedAverageCommonSharesOutstandingBasicAndDiluted	1978087926	shares
CY2024Q3	ahro	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.00
CY2023Q3	ahro	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.00
	ahro	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.00
	ahro	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.00
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-205538	usd
CY2024Q1	ahro	Reclassification Amount ReclassificationAmount	0	usd
CY2024Q1	ahro	Isusance Of Shares For Conversion Of Notes Amount IsusanceOfSharesForConversionOfNotesAmount	59752	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	79980	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1071951	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-1137757	usd
CY2024Q2	ahro	Isusance Of Shares For Conversion Of Notes Amount IsusanceOfSharesForConversionOfNotesAmount	151211	usd
CY2024Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	10500	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	920090	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-55956	usd
CY2024Q3	ahro	Isusance Of Shares For Conversion Of Debt IsusanceOfSharesForConversionOfDebt	20000	usd
CY2024Q3	ahro	Isusance Of Shares For Conversion Of Notes Amount IsusanceOfSharesForConversionOfNotesAmount	18750	usd
CY2024Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	44250	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-360993	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-333949	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-4516802	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	35000	usd
CY2023Q1	ahro	Adjustment Shares Issued Amount AdjustmentSharesIssuedAmount	0	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1209261	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-5691063	usd
CY2023Q2	ahro	Adjustment Shares Issued Amount AdjustmentSharesIssuedAmount	0	usd
CY2023Q2	ahro	Issuance Of Shares For Conversion Of Notes Amount IssuanceOfSharesForConversionOfNotesAmount	374695	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	981792	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-4334576	usd
CY2023Q3	ahro	Adjustment Shares Issued Amount AdjustmentSharesIssuedAmount	-35107	usd
CY2023Q3	ahro	Issuance Of Shares For Conversion Of Notes IssuanceOfSharesForConversionOfNotes	0	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-719901	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-5089584	usd
	us-gaap	Profit Loss ProfitLoss	-512854	usd
	us-gaap	Profit Loss ProfitLoss	-947369	usd
	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	-385011	usd
	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	348623	usd
	ahro	Gain Loss On Conversion Of Convertible Debt GainLossOnConversionOfConvertibleDebt	97125	usd
	ahro	Gain Loss On Conversion Of Convertible Debt GainLossOnConversionOfConvertibleDebt	0	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	46153	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	39435	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
	us-gaap	Depreciation Depreciation	21721	usd
	us-gaap	Depreciation Depreciation	33355	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	377089	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2882	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-33527	usd
	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	0	usd
	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	175000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	8065298	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	7988141	usd
CY2024Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2024Q3	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	38000000	usd
	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	In accordance with Section 382 of the U.S. Internal Revenue Code, the usage of the Company’s net operating loss carry forwards is subject to annual limitations following greater than 50% ownership changes. Tax returns for the years ended 2019 through 2023 are subject to review by the tax authorities
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	99593	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-10447	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	157380	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	80317	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-139049	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-271486	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	1501	usd
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	306	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	14831	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	27913	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	119030	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	15700	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	116785	usd
	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	72500	usd
	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	0	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	105000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
	us-gaap	Proceeds From Unsecured Notes Payable ProceedsFromUnsecuredNotesPayable	0	usd
	us-gaap	Proceeds From Unsecured Notes Payable ProceedsFromUnsecuredNotesPayable	127657	usd
	ahro	Proceeds From Self Liquidating Notes ProceedsFromSelfLiquidatingNotes	0	usd
	ahro	Proceeds From Self Liquidating Notes ProceedsFromSelfLiquidatingNotes	0	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	90636	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	42500	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	53250	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	139174	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	272049	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	125	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	563	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	125	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	563	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	ahro	Conversion Of Convertible Debt Into Common Stock ConversionOfConvertibleDebtIntoCommonStock	230963	usd
	ahro	Conversion Of Convertible Debt Into Common Stock ConversionOfConvertibleDebtIntoCommonStock	0	usd
CY2023Q2	ahro	Finite Lived Intangible Asset Estimate Useful Life FiniteLivedIntangibleAssetEstimateUsefulLife	P10Y
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-38551622	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-38038768	usd
	us-gaap	Profit Loss ProfitLoss	-512854	usd
	us-gaap	Profit Loss ProfitLoss	-947369	usd
CY2024Q3	ahro	Working Capital Deficit WorkingCapitalDeficit	-4728182	usd
CY2023Q4	ahro	Working Capital Deficit WorkingCapitalDeficit	-4998581	usd
CY2024Q3	us-gaap	Convertible Debt ConvertibleDebt	1051664	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	240853	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	240853	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	240853	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	219132	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	0	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21721	usd
	ahro	Depreciation Expense DepreciationExpense	21721	usd
	ahro	Depreciation Expense DepreciationExpense	33355	usd
	ahro	Amortization For The Intangible Assets AmortizationForTheIntangibleAssets	5030096	usd
CY2023	ahro	Amortization For The Intangible Assets AmortizationForTheIntangibleAssets	5030096	usd
	ahro	Less Accumulated Amortization LessAccumulatedAmortization	-635863	usd
CY2023	ahro	Less Accumulated Amortization LessAccumulatedAmortization	-258774	usd
	ahro	Amortization For The Intangible Assets Net AmortizationForTheIntangibleAssetsNet	4394233	usd
CY2023	ahro	Amortization For The Intangible Assets Net AmortizationForTheIntangibleAssetsNet	4771322	usd
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	377089	usd
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	919	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">At September 30, 2024, receivables from 3 customers represented 78% of the accounts receivable balance. </p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">During the nine months ended September 30, 2024, 80% of sales were through the Company’s agent channel.</p>
CY2024Q3	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	1248041	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	1633052	usd
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	604762	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	600000	shares
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2252573721	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2024420237	shares
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	ahro	Unsecured Note Payable UnsecuredNotePayable	99700	usd
CY2023Q4	ahro	Unsecured Note Payable UnsecuredNotePayable	99700	usd
CY2024Q3	ahro	Accrued Interest AccruedInterest	63989	usd
CY2023Q4	ahro	Accrued Interest AccruedInterest	60250	usd
CY2024Q3	us-gaap	Other Notes Payable OtherNotesPayable	163689	usd
CY2023Q4	us-gaap	Other Notes Payable OtherNotesPayable	159950	usd
CY2024Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1051664	usd
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1061793	usd
CY2024Q3	ahro	Convertible Note Payable Discount ConvertibleNotePayableDiscount	-2486	usd
CY2023Q4	ahro	Convertible Note Payable Discount ConvertibleNotePayableDiscount	-36921	usd
CY2024Q3	ahro	Accrued Interestate AccruedInterestate	408843	usd
CY2023Q4	ahro	Accrued Interestate AccruedInterestate	295986	usd
CY2024Q3	ahro	Convertible Notes And Accrued Interest ConvertibleNotesAndAccruedInterest	1458021	usd
CY2023Q4	ahro	Convertible Notes And Accrued Interest ConvertibleNotesAndAccruedInterest	1320858	usd
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	1633052	usd
	us-gaap	Derivative Fair Value Hedge Included In Effectiveness Gain Loss DerivativeFairValueHedgeIncludedInEffectivenessGainLoss	-385011	usd
CY2024Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	1248041	usd
CY2024Q3	ahro	Present Value Of Future Insurance Profits Amortization Expense Yearone PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearone	125175	usd
CY2024Q3	us-gaap	Present Value Of Future Insurance Profits Amortization Expense Year Two PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearTwo	500700	usd
CY2024Q3	us-gaap	Present Value Of Future Insurance Profits Amortization Expense Year Three PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearThree	500700	usd
CY2024Q3	us-gaap	Present Value Of Future Insurance Profits Amortization Expense Year Four PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearFour	500700	usd
CY2024Q3	us-gaap	Present Value Of Future Insurance Profits Amortization Expense Year Five PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearFive	500700	usd
CY2024Q3	ahro	Present Value Of Future Insurance Profits Amortization Expense Year Six PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearSix	500700	usd
CY2024Q3	ahro	Present Value Of Future Insurance Profits Amortization Expense PresentValueOfFutureInsuranceProfitsAmortizationExpense	2628675	usd
CY2024Q3	ahro	Present Value Of Future Insurance Profits Amortization Expense Year Thereafter PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearThereafter	1752450	usd
CY2024Q3	ahro	Total Estimated Future Amortization TotalEstimatedFutureAmortization	4381125	usd
	ahro	Net Cash Proceeds NetCashProceeds	75805	usd
	ahro	Net Cash Proceeds NetCashProceeds	27913	usd
	ahro	Advances From Related Parties Debt AdvancesFromRelatedPartiesDebt	484974	usd
	ahro	Advances From Related Parties Debt AdvancesFromRelatedPartiesDebt	560779	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1050401554	shares
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2433029215	shares

Files In Submission

Name	View Source	Status
ahro-20240930_def.xml	Edgar Link	unprocessable
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
0001477932-24-007452-index-headers.html	Edgar Link	pending
0001477932-24-007452-index.html	Edgar Link	pending
0001477932-24-007452.txt	Edgar Link	pending
0001477932-24-007452-xbrl.zip	Edgar Link	pending
ahro-20240930.xsd	Edgar Link	pending
ahro_10q.htm	Edgar Link	pending
ahro_ex311.htm	Edgar Link	pending
ahro_ex312.htm	Edgar Link	pending
ahro_ex321.htm	Edgar Link	pending
ahro_ex322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
ahro-20240930_cal.xml	Edgar Link	unprocessable
ahro-20240930_lab.xml	Edgar Link	unprocessable
ahro-20240930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ahro_10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AHRO
Authentic Holdings, Inc. Stock $ahro

2024 Q4 Form 10-Q Financial Statement

#000147793224007452 Filed on November 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AHRO Authentic Holdings, Inc. Stock $ahro

2024 Q4 Form 10-Q Financial Statement

#000147793224007452 Filed on November 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AHRO
Authentic Holdings, Inc. Stock $ahro